The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2 H -benzo[ d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2 H -benzo[ d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1 H -benzo[ d]imidazol-1-yl)propanenitrile (commonly known as N -propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these four specific substances.https://www.federalregister.gov/documents/2026/07/01/2026-13364/schedules-of-controlled-substances-temporary-placement-of-56--dichloro-brorphine-56-dichloro

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 7-hydroxymitragynine above a specified threshold.https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.https://www.federalregister.gov/documents/2026/07/06/2026-13581/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[ c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine. https://www.federalregister.gov/documents/2026/07/08/2026-13821/schedules-of-controlled-substances-placement-of-tianeptine-in-schedule-i

Quick recap The meeting focused on discussing the DEA's proposed scheduling of 7-OH (7-hydroxymitragynine) in Kratom products, with Christopher explaining that this is actually a threshold discussion rather than a complete ban. Christopher analyzed his strongest green mangda powder, which contained 0.00538% 7-OH, showing it falls about 89% below the proposed 0.05% limit, indicating that current products could remain legal under the new regulations. The group discussed how this affects different Kratom products, with extracts potentially being more impacted than powder forms, and Christopher noted that many commercial products already contained warnings about potentially having pseudoindoxyl and 7-OH. The conversation also covered personal experiences with Kratom usage, testing procedures, and concerns about the broader impact on the market, including how this might affect pain patients who rely on Kratom for relief. Summary Weather and Personal Updates Discussion The participants discussed weather conditions, with Christopher mentioning flooding and rain in his area, while Venus noted receiving flash flood warnings. Christopher shared that he has been struggling with sleep issues for about two years due to various responsibilities, but is starting to improve. The conversation briefly touched on legal proceedings involving KDA in Massachusetts, with Michael expressing concerns about address requirements during testimony. The conversation ended with Paul joining to check in, mentioning he was tired from an early start to his day. DEA Kratom Regulation Impact Analysis Christopher discussed the impact of DEA regulations on kratom products, noting that while they lost Tennessee and Kansas, the regulations aim to show differences between products and establish thresholds for 7-OH levels. He analyzed their strongest green mangda batch, which contained 0.00538% 7-OH, well below the proposed 0.050% limit. The group discussed how many existing kratom products, including those labeled as containing pseudoindoxyl or 7-OH, will no longer be legal, and Christopher expressed concern about the criminalization aspect of Schedule 1 classification while acknowledging the need for manufacturer responsibility.